Breaking News Instant updates and real-time market news.

LVGO

Livongo Health

$122.50 /

+11.3 (+10.16%)

, CVS

CVS Health

$64.28 /

+1 (+1.58%)

12:15
07/29/20
07/29
12:15
07/29/20
12:15

Livongo Health ending re-seller relationship with CVS Health, says RBC Capital

RBC Capital analyst Sean Dodge reported that Livongo Health (LVGO) said it has ended its re-seller relations ship with CVS Health (CVS), explaining that the latter is evolving its Transform Diabetes Care program to focus more on personalized interventions via its retail locations. Dodge said Livongo does not expect the change will have "all that meaningful" an impact on revenue and said it is reaching out to employers directly as contracts come up for renewal between now and the end of next year. The company believes it will be able to retain the majority of these contracts and Dodge thinks it can eliminate what he believes was a low-teens percentage sales commission to CVS in the process. Dodge keeps an Outperform rating and $120 price target on Livongo shares.

LVGO

Livongo Health

$122.50 /

+11.3 (+10.16%)

CVS

CVS Health

$64.28 /

+1 (+1.58%)

  • 05

    Aug

  • 06

    Aug

  • 17

    Aug

  • 14

    Sep

  • 12

    Dec

LVGO Livongo Health
$122.50 /

+11.3 (+10.16%)

07/15/20
Fly Intel: Top five analyst initiations
07/14/20 Credit Suisse
Livongo Health initiated with an Outperform at Credit Suisse
07/14/20 KeyBanc
UnitedHealth competition won't impact Livongo near term, says KeyBanc
07/14/20 Citi
Livongo Health initiated with a Buy at Citi
CVS CVS Health
$64.28 /

+1 (+1.58%)

07/01/20 SVB Leerink
CVS Health reinstated with a Market Perform at SVB Leerink
06/01/20 Stephens
Molina Healthcare price target raised to $215 from $202 at Stephens
05/14/20
Fly Intel: Top five analyst upgrades
05/14/20 Credit Suisse
CVS upgraded to Outperform on 'compelling' valuation at Credit Suisse

TODAY'S FREE FLY STORIES

Earnings
Acutus Medical sees Q2 revenue $3.8M-$5M, consensus $4.56M  16:14
05/12/21
05/12
16:14
05/12/21
16:14
AFIB

Acutus Medical

$11.64 /

-0.29 (-2.43%)

 
ShowHide Related Items >><<
AFIB Acutus Medical
$11.64 /

-0.29 (-2.43%)

AFIB Acutus Medical
$11.64 /

-0.29 (-2.43%)

03/19/21 Canaccord
Acutus Medical price target lowered to $16 from $30 at Canaccord
03/19/21 William Blair
Acutus Medical downgraded to Market Perform from Outperform at William Blair
03/19/21 JPMorgan
Acutus Medical downgraded to Neutral with $19 target at JPMorgan
03/19/21 JPMorgan
Acutus Medical downgraded to Neutral from Overweight at JPMorgan
AFIB Acutus Medical
$11.64 /

-0.29 (-2.43%)

  • 06
    Aug
AFIB Acutus Medical
$11.64 /

-0.29 (-2.43%)

AFIB Acutus Medical
$11.64 /

-0.29 (-2.43%)

Earnings
Datto sees Q2 revenue $146M-$148M, consensus $142.4M » 16:14
05/12/21
05/12
16:14
05/12/21
16:14
MSP

Datto

$24.38 /

-0.54 (-2.17%)

Sees Q2 adjusted EBITDA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MSP Datto
$24.38 /

-0.54 (-2.17%)

MSP Datto
$24.38 /

-0.54 (-2.17%)

03/15/21 Credit Suisse
Datto assumed with a Neutral at Credit Suisse
03/12/21 Mizuho
Datto price target lowered to $31 from $35 at Mizuho
03/09/21 BMO Capital
Datto price target lowered to $27 from $38 at BMO Capital
03/08/21 RBC Capital
Datto price target lowered to $34 from $39 at RBC Capital
MSP Datto
$24.38 /

-0.54 (-2.17%)

  • 21
    Oct
MSP Datto
$24.38 /

-0.54 (-2.17%)

MSP Datto
$24.38 /

-0.54 (-2.17%)

Earnings
Ramaco Resources reports Q1 EPS 10c, consensus 0c » 16:14
05/12/21
05/12
16:14
05/12/21
16:14
METC

Ramaco Resources

$4.21 /

-0.17 (-3.88%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
METC Ramaco Resources
$4.21 /

-0.17 (-3.88%)

METC Ramaco Resources
$4.21 /

-0.17 (-3.88%)

02/23/21 B. Riley Securities
Ramaco Resources price target raised to $9 from $8 at B. Riley Securities
02/22/21 Benchmark
Ramaco Resources assumed with a Buy at Benchmark
12/17/20 BMO Capital
Ramaco Resources downgraded to Market Perform from Outperform at BMO Capital
METC Ramaco Resources
$4.21 /

-0.17 (-3.88%)

Earnings
Billtrust reports Q1 EPS (16c), consensus (4c) » 16:14
05/12/21
05/12
16:14
05/12/21
16:14
BTRS

Billtrust

$12.60 /

-0.8 (-5.97%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BTRS Billtrust
$12.60 /

-0.8 (-5.97%)

BTRS Billtrust
$12.60 /

-0.8 (-5.97%)

04/30/21 JPMorgan
Billtrust initiated with a Neutral at JPMorgan
04/22/21 Cowen
Billtrust initiated with an Outperform at Cowen
03/18/21 KeyBanc
Billtrust initiated with an Overweight at KeyBanc
03/10/21 Needham
Billtrust initiated with a Buy at Needham
BTRS Billtrust
$12.60 /

-0.8 (-5.97%)

Earnings
Montrose Environmental backs FY21 revenue growth view 20% » 16:14
05/12/21
05/12
16:14
05/12/21
16:14
MEG

Montrose Environmental

$54.23 /

-0.74 (-1.35%)

Consensus $390.14M.…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MEG Montrose Environmental
$54.23 /

-0.74 (-1.35%)

MEG Montrose Environmental
$54.23 /

-0.74 (-1.35%)

04/21/21 JPMorgan
Montrose Environmental initiated with a Neutral at JPMorgan
04/06/21 Stifel
Montrose Environmental price target raised to $63 from $51 at Stifel
03/26/21 Morgan Stanley
Montrose Environmental initiated with an Equal Weight at Morgan Stanley
03/25/21 Needham
Montrose Environmental price target raised to $50 from $35 at Needham
MEG Montrose Environmental
$54.23 /

-0.74 (-1.35%)

  • 25
    Nov
  • 23
    Jul
Earnings
Datto reports Q1 EPS 18c, consensus 17c » 16:14
05/12/21
05/12
16:14
05/12/21
16:14
MSP

Datto

$24.32 /

-0.6 (-2.41%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MSP Datto
$24.32 /

-0.6 (-2.41%)

MSP Datto
$24.32 /

-0.6 (-2.41%)

03/15/21 Credit Suisse
Datto assumed with a Neutral at Credit Suisse
03/12/21 Mizuho
Datto price target lowered to $31 from $35 at Mizuho
03/09/21 BMO Capital
Datto price target lowered to $27 from $38 at BMO Capital
03/08/21 RBC Capital
Datto price target lowered to $34 from $39 at RBC Capital
MSP Datto
$24.32 /

-0.6 (-2.41%)

  • 21
    Oct
MSP Datto
$24.32 /

-0.6 (-2.41%)

MSP Datto
$24.32 /

-0.6 (-2.41%)

Earnings
Compass sees FY21 revenue $5.35B-$5.55B, consensus $5B » 16:13
05/12/21
05/12
16:13
05/12/21
16:13
COMP

Compass

$14.26 /

-1.13 (-7.34%)

Sees FY21 adjusted EBITDA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
COMP Compass
$14.26 /

-1.13 (-7.34%)

COMP Compass
$14.26 /

-1.13 (-7.34%)

04/26/21
Fly Intel: Top five analyst initiations
04/26/21 Morgan Stanley
Compass initiated with an Overweight at Morgan Stanley
04/26/21 Oppenheimer
Compass initiated with an Outperform at Oppenheimer
04/26/21 Loop Capital
Compass initiated with a Hold at Loop Capital
COMP Compass
$14.26 /

-1.13 (-7.34%)

  • 01
    Apr
COMP Compass
$14.26 /

-1.13 (-7.34%)

COMP Compass
$14.26 /

-1.13 (-7.34%)

COMP Compass
$14.26 /

-1.13 (-7.34%)

Earnings
Montrose Environmental reports Q1 EPS (62c), consensus (8c) » 16:13
05/12/21
05/12
16:13
05/12/21
16:13
MEG

Montrose Environmental

$54.23 /

-0.74 (-1.35%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MEG Montrose Environmental
$54.23 /

-0.74 (-1.35%)

MEG Montrose Environmental
$54.23 /

-0.74 (-1.35%)

04/21/21 JPMorgan
Montrose Environmental initiated with a Neutral at JPMorgan
04/06/21 Stifel
Montrose Environmental price target raised to $63 from $51 at Stifel
03/26/21 Morgan Stanley
Montrose Environmental initiated with an Equal Weight at Morgan Stanley
03/25/21 Needham
Montrose Environmental price target raised to $50 from $35 at Needham
MEG Montrose Environmental
$54.23 /

-0.74 (-1.35%)

  • 25
    Nov
  • 23
    Jul
Earnings
Amwell sees FY21 revenue $260M-$270M, consensus $266.21M » 16:13
05/12/21
05/12
16:13
05/12/21
16:13
AMWL

Amwell

$12.87 /

+0.17 (+1.34%)

Sees AMG visit volume…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AMWL Amwell
$12.87 /

+0.17 (+1.34%)

AMWL Amwell
$12.87 /

+0.17 (+1.34%)

05/04/21 Piper Sandler
Teladoc closed down 5% on three year old 'news,' says Piper Sandler
05/03/21 Cantor Fitzgerald
Teladoc competitive loss a gain for Amwell, says Cantor Fitzgerald
04/26/21 Piper Sandler
Piper Sandler 'incrementally bullish' on Amwell, Teladoc, 1Life
04/16/21 KeyBanc
Amwell initiated with a Sector Weight at KeyBanc
AMWL Amwell
$12.87 /

+0.17 (+1.34%)

  • 15
    Jan
  • 17
    Sep
AMWL Amwell
$12.87 /

+0.17 (+1.34%)

AMWL Amwell
$12.87 /

+0.17 (+1.34%)

Recommendations
Stephens says Wendy's remains a 2021 Best Idea after 'beat and raise' report » 16:13
05/12/21
05/12
16:13
05/12/21
16:13
WEN

Wendy's

$22.50 /

-0.3 (-1.32%)

Stephens analyst James…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WEN Wendy's
$22.50 /

-0.3 (-1.32%)

WEN Wendy's
$22.50 /

-0.3 (-1.32%)

14:45 Today Wedbush
Wedbush ups Wendy's price target to $28.50 following quarterly results
04/12/21 JPMorgan
Wendy's price target raised to $27 from $25 at JPMorgan
03/24/21 Wedbush
Wendy's added to Best Ideas List at Wedbush
03/22/21
Fly Intel: Top five analyst downgrades
WEN Wendy's
$22.50 /

-0.3 (-1.32%)

WEN Wendy's
$22.50 /

-0.3 (-1.32%)

WEN Wendy's
$22.50 /

-0.3 (-1.32%)

WEN Wendy's
$22.50 /

-0.3 (-1.32%)

Earnings
Acutus Medical reports Q1 EPS 97c, consensus (81c) » 16:13
05/12/21
05/12
16:13
05/12/21
16:13
AFIB

Acutus Medical

$11.60 /

-0.33 (-2.77%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AFIB Acutus Medical
$11.60 /

-0.33 (-2.77%)

AFIB Acutus Medical
$11.60 /

-0.33 (-2.77%)

03/19/21 Canaccord
Acutus Medical price target lowered to $16 from $30 at Canaccord
03/19/21 William Blair
Acutus Medical downgraded to Market Perform from Outperform at William Blair
03/19/21 JPMorgan
Acutus Medical downgraded to Neutral with $19 target at JPMorgan
03/19/21 JPMorgan
Acutus Medical downgraded to Neutral from Overweight at JPMorgan
AFIB Acutus Medical
$11.60 /

-0.33 (-2.77%)

  • 06
    Aug
AFIB Acutus Medical
$11.60 /

-0.33 (-2.77%)

AFIB Acutus Medical
$11.60 /

-0.33 (-2.77%)

Earnings
Amwell reports Q1 EPS (16c), consensus (19c) » 16:12
05/12/21
05/12
16:12
05/12/21
16:12
AMWL

Amwell

$12.87 /

+0.17 (+1.34%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AMWL Amwell
$12.87 /

+0.17 (+1.34%)

AMWL Amwell
$12.87 /

+0.17 (+1.34%)

05/04/21 Piper Sandler
Teladoc closed down 5% on three year old 'news,' says Piper Sandler
05/03/21 Cantor Fitzgerald
Teladoc competitive loss a gain for Amwell, says Cantor Fitzgerald
04/26/21 Piper Sandler
Piper Sandler 'incrementally bullish' on Amwell, Teladoc, 1Life
04/16/21 KeyBanc
Amwell initiated with a Sector Weight at KeyBanc
AMWL Amwell
$12.87 /

+0.17 (+1.34%)

  • 15
    Jan
  • 17
    Sep
AMWL Amwell
$12.87 /

+0.17 (+1.34%)

AMWL Amwell
$12.87 /

+0.17 (+1.34%)

Earnings
Compass sees Q2 revenue $1.5B-$1.6B, consensus $1.27B » 16:12
05/12/21
05/12
16:12
05/12/21
16:12
COMP

Compass

$14.25 /

-1.14 (-7.41%)

Sees Q2 adjusted EBITDA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
COMP Compass
$14.25 /

-1.14 (-7.41%)

COMP Compass
$14.25 /

-1.14 (-7.41%)

04/26/21
Fly Intel: Top five analyst initiations
04/26/21 Morgan Stanley
Compass initiated with an Overweight at Morgan Stanley
04/26/21 Oppenheimer
Compass initiated with an Outperform at Oppenheimer
04/26/21 Loop Capital
Compass initiated with a Hold at Loop Capital
COMP Compass
$14.25 /

-1.14 (-7.41%)

  • 01
    Apr
COMP Compass
$14.25 /

-1.14 (-7.41%)

COMP Compass
$14.25 /

-1.14 (-7.41%)

COMP Compass
$14.25 /

-1.14 (-7.41%)

Hot Stocks
Boot Barn sees FY22 new unit growth of 10% » 16:12
05/12/21
05/12
16:12
05/12/21
16:12
BOOT

Boot Barn

$67.43 /

-5.03 (-6.94%)

The company is not…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BOOT Boot Barn
$67.43 /

-5.03 (-6.94%)

BOOT Boot Barn
$67.43 /

-5.03 (-6.94%)

02/10/21 Cowen
Boot Barn price target raised to $68 from $65 at Cowen
01/26/21 Jefferies
Boot Barn price target raised to $72 from $68 at Jefferies
01/26/21 Craig-Hallum
Boot Barn price target raised to $54 from $48 at Craig-Hallum
01/26/21 William Blair
Boot Barn valuation remains 'compelling,' says William Blair
BOOT Boot Barn
$67.43 /

-5.03 (-6.94%)

BOOT Boot Barn
$67.43 /

-5.03 (-6.94%)

BOOT Boot Barn
$67.43 /

-5.03 (-6.94%)

Earnings
Relmada Therapeutics reports Q1 EPS ($1.34), consensus ($1.39) » 16:12
05/12/21
05/12
16:12
05/12/21
16:12
RLMD

Relmada Therapeutics

$33.70 /

-1.32 (-3.77%)

"We continue to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RLMD Relmada Therapeutics
$33.70 /

-1.32 (-3.77%)

RLMD Relmada Therapeutics
$33.70 /

-1.32 (-3.77%)

10/28/20 Goldman Sachs
Relmada Therapeutics downgraded to Neutral from Buy at Goldman Sachs
07/13/20 Oppenheimer
Relmada Therapeutics initiated with an Outperform at Oppenheimer
05/27/20 Goldman Sachs
Goldman says Relmada clearance for Phase 3 supports REL-1017 safety, efficacy
RLMD Relmada Therapeutics
$33.70 /

-1.32 (-3.77%)

Hot Stocks
ContextLogic names Jacqueline Reses executive chair » 16:12
05/12/21
05/12
16:12
05/12/21
16:12
WISH

ContextLogic

$11.43 /

-0.315 (-2.68%)

ContextLogic announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WISH ContextLogic
$11.43 /

-0.315 (-2.68%)

WISH ContextLogic
$11.43 /

-0.315 (-2.68%)

04/05/21 Evercore ISI
ContextLogic initiated with an Outperform at Evercore ISI
03/30/21 Loop Capital
ContextLogic to 'lap' easy comparisons in Q1, says Loop Capital
03/18/21 JPMorgan
ContextLogic shares attractive at current levels, says JPMorgan
03/09/21 Stifel
ContextLogic price target lowered to $20 from $22 at Stifel
WISH ContextLogic
$11.43 /

-0.315 (-2.68%)

  • 16
    Dec
WISH ContextLogic
$11.43 /

-0.315 (-2.68%)

WISH ContextLogic
$11.43 /

-0.315 (-2.68%)

WISH ContextLogic
$11.43 /

-0.315 (-2.68%)

Earnings
NV5 Global sees FY21 adjusted EPS $4.05-$4.45, consensus $4.00 » 16:12
05/12/21
05/12
16:12
05/12/21
16:12
NVEE

NV5 Global

$81.45 /

-4.55 (-5.29%)

Sees FY21 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NVEE NV5 Global
$81.45 /

-4.55 (-5.29%)

NVEE NV5 Global
$81.45 /

-4.55 (-5.29%)

03/29/21 Roth Capital
Roth Capital positive on NV5 acquisition of Geodynamics
03/15/21 Baird
NV5 Global initiated with an Outperform at Baird
01/13/21 Roth Capital
NV5 Global price target raised to $136 from $82 at Roth Capital
11/12/20 Roth Capital
NV5 Global price target raised to $82 from $77 at Roth Capital
NVEE NV5 Global
$81.45 /

-4.55 (-5.29%)

  • 11
    Mar
NVEE NV5 Global
$81.45 /

-4.55 (-5.29%)

Earnings
Boot Barn reports Q4 EPS ex-tax benefit 75c, consensus 47c » 16:12
05/12/21
05/12
16:12
05/12/21
16:12
BOOT

Boot Barn

$67.43 /

-5.03 (-6.94%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BOOT Boot Barn
$67.43 /

-5.03 (-6.94%)

BOOT Boot Barn
$67.43 /

-5.03 (-6.94%)

02/10/21 Cowen
Boot Barn price target raised to $68 from $65 at Cowen
01/26/21 Jefferies
Boot Barn price target raised to $72 from $68 at Jefferies
01/26/21 Craig-Hallum
Boot Barn price target raised to $54 from $48 at Craig-Hallum
01/26/21 William Blair
Boot Barn valuation remains 'compelling,' says William Blair
BOOT Boot Barn
$67.43 /

-5.03 (-6.94%)

BOOT Boot Barn
$67.43 /

-5.03 (-6.94%)

BOOT Boot Barn
$67.43 /

-5.03 (-6.94%)

Earnings
ContextLogic sees Q2 revenue $715M-$730M, consensus $759.13M » 16:11
05/12/21
05/12
16:11
05/12/21
16:11
WISH

ContextLogic

$11.45 /

-0.295 (-2.51%)

Sees Q2 adjusted EBITDA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WISH ContextLogic
$11.45 /

-0.295 (-2.51%)

WISH ContextLogic
$11.45 /

-0.295 (-2.51%)

04/05/21 Evercore ISI
ContextLogic initiated with an Outperform at Evercore ISI
03/30/21 Loop Capital
ContextLogic to 'lap' easy comparisons in Q1, says Loop Capital
03/18/21 JPMorgan
ContextLogic shares attractive at current levels, says JPMorgan
03/09/21 Stifel
ContextLogic price target lowered to $20 from $22 at Stifel
WISH ContextLogic
$11.45 /

-0.295 (-2.51%)

  • 16
    Dec
WISH ContextLogic
$11.45 /

-0.295 (-2.51%)

WISH ContextLogic
$11.45 /

-0.295 (-2.51%)

WISH ContextLogic
$11.45 /

-0.295 (-2.51%)

Earnings
Compass reports Q1 EPS ($1.67), consensus (25c) » 16:11
05/12/21
05/12
16:11
05/12/21
16:11
COMP

Compass

$14.34 /

-1.05 (-6.82%)

Reports Q1 revenue $1.1B,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
COMP Compass
$14.34 /

-1.05 (-6.82%)

COMP Compass
$14.34 /

-1.05 (-6.82%)

04/26/21
Fly Intel: Top five analyst initiations
04/26/21 Morgan Stanley
Compass initiated with an Overweight at Morgan Stanley
04/26/21 Oppenheimer
Compass initiated with an Outperform at Oppenheimer
04/26/21 Loop Capital
Compass initiated with a Hold at Loop Capital
  • 01
    Apr
COMP Compass
$14.34 /

-1.05 (-6.82%)

COMP Compass
$14.34 /

-1.05 (-6.82%)

COMP Compass
$14.34 /

-1.05 (-6.82%)

Hot Stocks
Vroom sees triple digit y/y growth in ecommerce unit sales for FY21  16:11
05/12/21
05/12
16:11
05/12/21
16:11
VRM

Vroom

$35.40 /

-1.44 (-3.91%)

 
ShowHide Related Items >><<
VRM Vroom
$35.40 /

-1.44 (-3.91%)

VRM Vroom
$35.40 /

-1.44 (-3.91%)

04/13/21 Wedbush
Vroom added to Best List Ideas at Wedbush
04/07/21 Raymond James
Raymond James starts Vroom at Outperform on digital auto secular growth
04/07/21 Raymond James
Vroom initiated with an Outperform at Raymond James
03/04/21 Truist
Vroom price target lowered to $54 from $58 at Truist
VRM Vroom
$35.40 /

-1.44 (-3.91%)

  • 07
    Dec
  • 11
    Sep
  • 09
    Jun
VRM Vroom
$35.40 /

-1.44 (-3.91%)

VRM Vroom
$35.40 /

-1.44 (-3.91%)

VRM Vroom
$35.40 /

-1.44 (-3.91%)

Upgrade
Array Technologies upgraded to Outperform at Credit Suisse following pullback » 16:11
05/12/21
05/12
16:11
05/12/21
16:11
ARRY

Array Technologies

$13.42 /

-11.54 (-46.23%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ARRY Array Technologies
$13.42 /

-11.54 (-46.23%)

ARRY Array Technologies
$13.42 /

-11.54 (-46.23%)

16:10 Today Credit Suisse
Array Technologies upgraded to Outperform at Credit Suisse following pullback
16:06 Today Credit Suisse
Array Technologies upgraded to Outperform from Neutral at Credit Suisse
06:07 Today Piper Sandler
Array Technologies downgraded to Neutral from Overweight at Piper Sandler
05:57 Today Barclays
Array Technologies downgraded to Underweight from Overweight at Barclays
ARRY Array Technologies
$13.42 /

-11.54 (-46.23%)

  • 19
    Mar
  • 03
    Dec
  • 15
    Oct
ARRY Array Technologies
$13.42 /

-11.54 (-46.23%)

Earnings
Vroom sees Q2 EPS (58c)-(51c), cosnensus (44c) » 16:11
05/12/21
05/12
16:11
05/12/21
16:11
VRM

Vroom

$35.40 /

-1.44 (-3.91%)

Sees Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VRM Vroom
$35.40 /

-1.44 (-3.91%)

VRM Vroom
$35.40 /

-1.44 (-3.91%)

04/13/21 Wedbush
Vroom added to Best List Ideas at Wedbush
04/07/21 Raymond James
Raymond James starts Vroom at Outperform on digital auto secular growth
04/07/21 Raymond James
Vroom initiated with an Outperform at Raymond James
03/04/21 Truist
Vroom price target lowered to $54 from $58 at Truist
VRM Vroom
$35.40 /

-1.44 (-3.91%)

  • 07
    Dec
  • 11
    Sep
  • 09
    Jun
VRM Vroom
$35.40 /

-1.44 (-3.91%)

VRM Vroom
$35.40 /

-1.44 (-3.91%)

VRM Vroom
$35.40 /

-1.44 (-3.91%)

Earnings
ContextLogic reports Q1 revenue $772M, consensus $743.09M » 16:11
05/12/21
05/12
16:11
05/12/21
16:11
WISH

ContextLogic

$11.46 /

-0.28 (-2.39%)

Reports Q1 adjusted…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WISH ContextLogic
$11.46 /

-0.28 (-2.39%)

WISH ContextLogic
$11.46 /

-0.28 (-2.39%)

04/05/21 Evercore ISI
ContextLogic initiated with an Outperform at Evercore ISI
03/30/21 Loop Capital
ContextLogic to 'lap' easy comparisons in Q1, says Loop Capital
03/18/21 JPMorgan
ContextLogic shares attractive at current levels, says JPMorgan
03/09/21 Stifel
ContextLogic price target lowered to $20 from $22 at Stifel
WISH ContextLogic
$11.46 /

-0.28 (-2.39%)

  • 16
    Dec
WISH ContextLogic
$11.46 /

-0.28 (-2.39%)

WISH ContextLogic
$11.46 /

-0.28 (-2.39%)

WISH ContextLogic
$11.46 /

-0.28 (-2.39%)

Hot Stocks
Vroom reports Q1 ecommerce units sold of 15,504, up 96% y/y » 16:10
05/12/21
05/12
16:10
05/12/21
16:10
VRM

Vroom

$35.39 /

-1.45 (-3.94%)

Paul Hennessy, CEO of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VRM Vroom
$35.39 /

-1.45 (-3.94%)

VRM Vroom
$35.39 /

-1.45 (-3.94%)

04/13/21 Wedbush
Vroom added to Best List Ideas at Wedbush
04/07/21 Raymond James
Raymond James starts Vroom at Outperform on digital auto secular growth
04/07/21 Raymond James
Vroom initiated with an Outperform at Raymond James
03/04/21 Truist
Vroom price target lowered to $54 from $58 at Truist
VRM Vroom
$35.39 /

-1.45 (-3.94%)

  • 07
    Dec
  • 11
    Sep
  • 09
    Jun
VRM Vroom
$35.39 /

-1.45 (-3.94%)

VRM Vroom
$35.39 /

-1.45 (-3.94%)

VRM Vroom
$35.39 /

-1.45 (-3.94%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.